This facility makes it possible to conduct biophysical studies of macromolecules, nanoparticles, and polymers in solution. Providing information about structure, coiling, molecular binding, dissociation constants, stability, size, shape, and oligomeric state
Nuclear magnetic resonance is an alternative technique that is widely used to resolve the atomic structure of proteins, particularly those with low molecular weights which do not form crystals
Proteomics based on state-of-the-art mass spectrometry for CNPEM’s internal and external users. The MAS lab comprises the sample preparation lab, the instrumentation lab, and the data analysis lab
Projeto do CNPEM com universidade holandesa disponibiliza bolsa de PD em Engenharia de Tecidos O Centro Nacional de Pesquisa em Energia e Materiais (CNPEM), em parceria com o Radboud University Medical Center (Radboudumc), nos Países Baixos, dispõe de uma vaga de pós-doutorado, com apoio da Fundação de Amparo à Pesquisa do Estado de São Paulo…
Bioinformatics laboratory Home /2024/Page 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc justo odio, vestibulum ac semper ac, rutrum quis urna. Duis molestie risus at convallis luctus. Curabitur lobortis convallis nulla, et ornare sapien ullamcorper id. Maecenas eu nulla euismod, gravida orci eget, ultricies velit. Sed eget volutpat magna. Etiam sed velit id…
Trabalho realizado no Centro busca suprir demanda nacional interna, tanto de testes de toxicidade de fármacos e cosméticos como opção alternativa aos testes com animais, quanto de produção própria de curativos com células humanas, que não podem ser importados
We produce recombinant viral vectors for vaccines and advanced therapies, using recombinant DNA technology to modify cells in order to express or silence a molecular target
We establish scientific and technological competencies for pharmaceutical inputs, including lineages to produce recombinant proteins for innovative medications and biosimilars
Tissue engineering for 3D culture and bioprinting with therapeutic applications and to develop alternatives to animal testing that are robust and mimic in vivo assays
We develop gene therapies using CRISPR/Cas9 to correct mutations, working towards safe and effective therapeutic applications for human genetic diseases that do not yet have medical alternatives